Caterina Lonati

Research activity is aimed at implementation of Machine Perfusion (MP) technique in pre-clinical and clinical settings. The main focus is the investigation of the bio-molecular and metabolic profile of ex-situ-perfused organs in order to identify the deleterious changes induced by ischemia/reperfusion (IR). Another relevant research aim is the development of an advanced reconditioning platform to harness the beneficial effects of Mesenchymal stem cells (MSCs) during liver MP.